Lantheus Holdings, Inc. (LNTH) Earnings Call Analysis
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic
Next earnings call: 2026-08-06
(Q2 2026)
— full calendar
Earnings Reports
-
Lantheus (LNTH) Q1 2026: NeuroSeq Jumps 14%, Setting Up 2027 Growth Surge
May 07, 2026
-
LNTH Q4 2025: NeuroSeq Triples Growth as Lantheus Refocuses on Diagnostics
February 26, 2026
-
Lantheus (LNTH) Q3 2025: Polarify Volumes Rise 3.3% Amid Margin Compression and Leadership Transition
November 06, 2025
-
LNTH Q2 2025: Polarify Revenue Cut by $60M as Price Compression Forces Strategic Reset
August 06, 2025
-
Lantheus (LNTH) Q1 2025: SPECT Divestiture Unlocks 200bps Margin Tailwind as Portfolio Shifts to PET
July 07, 2025